:: Library Catalog

Buchumschlag

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Masaki Shiota, Linghua Xu, Tomoyo Oguri, Masayuki Tanaka
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2026
Schlagworte:	Prostate Cancer
Online-Zugang:	https://onlinelibrary.wiley.com/doi/10.1155/proc/9964591
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Number of Prescription Medications and Overall Survival in Metastatic Castrate‐Resistant Prostate Cancer
von: Carley R. Pickett, et al.
Veröffentlicht: (2024)

Evaluation of Second‐Line Treatment for Castration‐Resistant Prostate Cancer following the Administration of Upfront Androgen Receptor Signaling Inhibitors
von: Kazuro Kikkawa, et al.
Veröffentlicht: (2024)

Skeletal Muscle Loss During Treatment With Abiraterone in Patients With Metastatic Prostate Cancer
von: Eva Streckova, et al.
Veröffentlicht: (2025)

Directed Evolution Restored Castrate Sensitivity in a Patient With Castrate Resistant Metastatic Prostate Cancer
von: Robert A. Gatenby, et al.
Veröffentlicht: (2025)

Efficacy, Safety, and Cost‐Effectiveness of Reduced versus Full Initial Doses of Androgen Receptor Signaling Inhibitors in Non‐Metastatic Castration‐Resistant Prostate Cancer: A Multicenter Retrospective Study
von: Himawari Asanuma, et al.
Veröffentlicht: (2026)

Comparative Effectiveness of First‐Line Treatments for Castration‐Resistant Prostate Cancer: A Large‐Scale Retrospective Study in Japan
von: Akihito Hashizume, et al.
Veröffentlicht: (2025)

Real‐World Overall Survival Comparison of Enzalutamide and Abiraterone In First‐ and Second‐Line Setting of Metastatic Castration‐Resistant Prostate Cancer
von: András Horváth, et al.
Veröffentlicht: (2025)

Determinants of the Cost of Illness in Iranian Prostate Cancer Patients
von: Ramin Ravangard, et al.
Veröffentlicht: (2026)

The Impact of Tumor Microenvironmental Acidity on Bicalutamide Sensitivity in Prostate Cancer Cells
von: Pedram Golmohammadi, et al.
Veröffentlicht: (2026)

Metformin and Flutamide Combination Therapy’s Efficacy and Safety in Prostate Cancer Cell Lines
von: AhmadReza Rezaeian, et al.
Veröffentlicht: (2026)

Castration Resistance Accelerates Prostate Cancer Kinetics
von: Sheila Jonnatan, et al.
Veröffentlicht: (2026)

Outcome of Subsequent Therapies After 177Lu‐Vipivotide Tetraxetan for Metastatic Castrate‐Resistant Prostate Cancer: A Tertiary Cancer Center Experience
von: Meryam Losee, et al.
Veröffentlicht: (2025)

Providing a Prostate Cancer Detection and Prevention Method With Developed Deep Learning Approach
von: Alireza Zarei, et al.
Veröffentlicht: (2025)

Inhibition of Growth and Induction of Apoptosis of Human Prostate Cancer Cells by Enzymatic Blockage of Kallikreins
von: Fabienne Lehner, et al.
Veröffentlicht: (2026)

Preliminary Evidence on Safety and Clinical Efficacy of Luteolin for Patients With Prostate Cancer Under Active Surveillance
von: Taku Naiki, et al.
Veröffentlicht: (2025)

In Vitro Effects of Cabazitaxel and Menadione on Cell Growth, Metabolism, and Transcriptomic Profile of Human Prostate Cancer Cell Lines
von: Ana Laura Gómez-Rosas, et al.
Veröffentlicht: (2026)

MRI‐Determined Tumor Contact Area as a Predictor of Pathological Extraprostatic Extension in Clinical T2 Prostate Cancer
von: Masashi Tsujimoto, et al.
Veröffentlicht: (2025)

Efficacy and Feasibility of Cabazitaxel for Very Elderly Patients of ≥ 80 Years of Age With Metastatic Castration‐Resistant Prostate Cancer: A Real‐World Multi‐Intuitional Analysis
von: Kotaro Suzuki, et al.
Veröffentlicht: (2025)

Association of Weight Loss and BMI on PSA Levels and Overall Survival in Veterans With Metastatic Castrate‐Resistant Prostate Cancer
von: Nicholas Fedele, et al.
Veröffentlicht: (2025)

Development of Mouse‐Tumor Model Using Prostate Cancer (PC3) Cell Line for High‐Intensity Focused Ultrasound (HIFU) Ablation
von: Nabin Khanal, et al.
Veröffentlicht: (2025)

Change in Clinical Management of Localized Prostate Cancer Patients at a Tertiary Medical Center as a Result of SARS‐CoV‐2 (COVID‐19)
von: Alexander Yaney, et al.
Veröffentlicht: (2026)

Dorsomorphin Suppresses EMT to Reduce AR‐Negative Prostate Cancer Metastasis by Synergistically Antagonizing JAK2/STAT3 and Gli2‐Independent Shh Activation
von: Dongzhang Li, et al.
Veröffentlicht: (2025)

Impact of the Nadir Androgen Receptor Signaling Inhibitor‐Derived Integrative Response Model in Real‐World Patients With Metastatic Castration‐Sensitive Prostate Cancer
von: Kazuma Yukihiro, et al.
Veröffentlicht: (2026)

Establishment and Characterization of Patient‐Derived Xenograft Organoids for Personalized Treatment of Castration‐Resistant Prostate Cancer
von: Takuro Sunada, et al.
Veröffentlicht: (2026)

Reliability of Negative Prostate MRI for Biopsy Decision‐Making in the Male Han Chinese Population
von: Fangming Wang, et al.
Veröffentlicht: (2026)

Immunohistochemical Detection of CD147 Expression in Adenocarcinoma of the Prostate: A Case‐Control Study
von: Sara Suliman, et al.
Veröffentlicht: (2024)

Comments on the Study “Adapting the Bellmunt Risk Score for Prognostic Stratification in Metastatic Castration‐Sensitive Prostate Cancer”
von: Xian Wen
Veröffentlicht: (2026)

Autocrine Fibroblast Growth Factor Receptor 1 Signaling Activates Lactate Dehydrogenase A‐Aerobic Glycolysis for Advanced Human Prostate Tumor Growth
von: Xiaoming Xu, et al.
Veröffentlicht: (2025)

Effects of Concurrent Administration of Spironolactone in Veterans with Metastatic Prostate Cancer Receiving Abiraterone: A Real‐World Retrospective Study
von: Erum Z. Whyne, et al.
Veröffentlicht: (2024)

Surgical Wait Time Is Not Associated With Oncological or Psychosocial Outcomes After Robotic Radical Prostatectomy
von: Juliette Cotte, et al.
Veröffentlicht: (2025)

Comprehensive Genomic Profiling Testing for Castration‐Resistant Prostate Cancer in Advanced Elderly Patients: A Single‐Center Retrospective Cohort Study
von: Takafumi Fukushima, et al.
Veröffentlicht: (2025)

Restoration of Mitochondrial Function: A Metabolic Perspective on “Directed Evolution” in Castration‐Resistant Prostate Cancer
von: Po‐Jung Su, et al.
Veröffentlicht: (2026)

Immunohistochemical Analysis of Androgen Receptor Expression Predicts the Prognosis of Metastatic Castration‐Sensitive Prostate Cancer Patients Receiving Abiraterone Acetate
von: Mitsuhisa Nishimoto, et al.
Veröffentlicht: (2025)

Baseline Imaging Derived Factors of Response Following [225Ac]Ac‐J591 Therapy in Metastatic Castration‐Resistant Prostate Cancer: A Lesion Level Analysis
von: Judith Stangl‐Kremser, et al.
Veröffentlicht: (2025)

Towards Precision Oncology: A New Predictive Machine Learning Model for Early Progression to Castration Resistant Prostate Cancer
von: Miguel Ángel Gómez‐Luque, et al.
Veröffentlicht: (2025)

A Phase II, Single Arm, Multicentre Trial of Triamcinolone With a GnRH Analog for Castrate‐Resistant Prostate Cancer (TRICREST)
von: Kenrick Ng, et al.
Veröffentlicht: (2025)

Reply to Letter to the Editor on “Impact of proton pump inhibitors on the efficacy of androgen receptor signaling inhibitors in metastatic castration‐resistant prostate cancer patients”
von: Tokiyoshi Tanegashima, et al.
Veröffentlicht: (2024)

Prognostic Nutritional Index as a Biomarker in Metastatic Hormone‐Sensitive Prostate Cancer: Impact on Survival and Treatment Optimization
von: Muhammet Bekir Hacioglu, et al.
Veröffentlicht: (2025)

Downregulation of NONO Suppresses Proliferation, Migration, and Invasion in Metastatic Prostate Cancer
von: Anna‐Lena Lemster, et al.
Veröffentlicht: (2025)

Genetics‐Driven, Intensity‐Modulated Adaptive Management of Patients With Metastatic Prostate Cancer
von: Reynier D. Rodriguez Rosales, et al.
Veröffentlicht: (2025)